Top

Molecular Cancer

Published in:

Open Access 01-12-2013 | Research

Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells

Authors: Siddik Sarkar, Shashi Rajput, Amit Kumar Tripathi, Mahitosh Mandal

Published in: Molecular Cancer | Issue 1/2013

Abstract

Background

The hypoxic environment of tumor region stimulated the up regulation of growth factors responsible for angiogenesis and tumor proliferation. Thus, targeting the tumor vasculature along with the proliferation by dual tyrosine kinase inhibitor may be the efficient way of treating advanced breast cancers, which can be further enhanced by combining with radiotherapy. However, the effectiveness of radiotherapy may be severely compromised by toxicities and tumor resistance due to radiation-induced adaptive response contributing to recurrence and metastases of breast cancer. The rational of using ZD6474 is to evaluate the feasibility and efficacy of combined VEGFR2 and EGFR targeting with concurrent targeted and localized UV-B phototherapy in vitro breast cancer cells with the anticipation to cure skin lesions infiltrated with breast cancer cells.

Materials and methods

Breast cancer cells were exposed to UV-B and ZD6474 and the cell viability, apoptosis, invasion and motility studies were conducted for the combinatorial effect. Graphs and statistical analyses were performed using Graph Pad Prism 5.0.

Results

ZD6474 and UV-B decreased cell viability in breast cancers in combinatorial manner without affecting the normal human mammary epithelial cells. ZD6474 inhibited cyclin E expression and induced p53 expression when combined with UV-B. It activated stress induced mitochondrial pathway by inducing translocation of bax and cytochrome-c. The combination of ZD6474 with UV-B vs. either agent alone also more potently down-regulated the anti-apoptotic bcl-2 protein, up-regulated pro-apoptotic signaling events involving expression of bax, activation of caspase-3 and caspase-7 proteins, and induced poly (ADP-ribose) polymerase resulting in apoptosis. ZD6474 combined with UV-B inhibited invasion of breast cancer cells in vitro as compared to either single agent, indicating a potential involvement of pro-angiogenic growth factors in regulating the altered expression and reorganization of cytoskeletal proteins in combinatorial treated breast cancer cells. Involvement of combination therapy in reducing the expression of matrix metalloprotease was also observed.

Conclusions

Collectively, our studies indicate that incorporating an anti-EGFR plus VEGFR strategy (ZD6474) with phototherapy (UV-B), an alternative approach to the ongoing conventional radiotherapy for the treatment of infiltrating metastatic breast cancer cells in the skin and for locally recurrence breast cancer than either approach alone.

Available only for authorised users

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005, 366: 2087-2106.CrossRefPubMed

Gyenes G: Radiation-induced ischemic heart disease in breast cancer–a review. Acta oncologica. 1998, 37: 241-246. 10.1080/028418698429522CrossRefPubMed

Arbetter KR, Prakash UB, Tazelaar HD, Douglas WW: Radiation-induced pneumonitis in the “nonirradiated” lung. Mayo Clin Proc. 1999, 74: 27-36. 10.4065/74.1.27CrossRefPubMed

Zhang Z, Shao S, Meistrich ML: The radiation-induced block in spermatogonial differentiation is due to damage to the somatic environment, not the germ cells. J Cell Physiol. 2007, 211: 149-158. 10.1002/jcp.20910CrossRefPubMed

Cao N, Li S, Wang Z, Ahmed KM, Degnan ME, Fan M, Dynlacht JR, Li JJ: NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance. Radiat Res. 2009, 171: 9-21. 10.1667/RR1472.1PubMedCentralCrossRefPubMed

Li T, Zeng ZC, Wang L, Qiu SJ, Zhou JW, Zhi XT, Yu HH, Tang ZY: Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial-mesenchymal transition. Cancer Gene Ther. 2011, 18: 617-626. 10.1038/cgt.2011.29CrossRefPubMed

Maverakis E, Miyamura Y, Bowen MP, Correa G, Ono Y, Goodarzi H: Light, including ultraviolet. J Autoimmun. 2010, 34: J247-J257. 10.1016/j.jaut.2009.11.011PubMedCentralCrossRefPubMed

Lee E, Koo J, Berger T: UVB phototherapy and skin cancer risk: a review of the literature. Int J Dermatol. 2005, 44: 355-360. 10.1111/j.1365-4632.2004.02186.xCrossRefPubMed

Fabris C, Valduga G, Miotto G, Borsetto L, Jori G, Garbisa S, Reddi E: Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. Cancer research. 2001, 61: 7495-7500.PubMed

10.

Takeuchi S, Zhang W, Wakamatsu K, Ito S, Hearing VJ, Kraemer KH, Brash DE: Melanin acts as a potent UVB photosensitizer to cause an atypical mode of cell death in murine skin. Proc Natl Acad Sci U S A. 2004, 101: 15076-15081. 10.1073/pnas.0403994101PubMedCentralCrossRefPubMed

11.

Mitchell DL, Nairn RS: The biology of the (6–4) photoproduct. Photochem Photobiol. 1989, 49: 805-819. 10.1111/j.1751-1097.1989.tb05578.xCrossRefPubMed

12.

Chadwick CA, Potten CS, Nikaido O, Matsunaga T, Proby C, Young AR: The detection of cyclobutane thymine dimers, (6–4) photolesions and the Dewar photoisomers in sections of UV-irradiated human skin using specific antibodies, and the demonstration of depth penetration effects. J Photochem Photobiol B Biol. 1995, 28: 163-170. 10.1016/1011-1344(94)07096-7.CrossRef

13.

Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W: Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 1998, 94: 339-352. 10.1016/S0092-8674(00)81477-4CrossRefPubMed

14.

Kulms D, Schwarz T: Independent contribution of three different pathways to ultraviolet-B-induced apoptosis. Biochem Pharmacol. 2002, 64: 837-841. 10.1016/S0006-2952(02)01146-2CrossRefPubMed

15.

Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, Weichselbaum RR: Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 1999, 59: 3374-3378.PubMed

16.

Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB: Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 1997, 15: 1191-1197. 10.1038/sj.onc.1201275CrossRefPubMed

17.

Dent P, Reardon DB, Park JS, Bowers G, Logsdon C, Valerie K, Schmidt-Ullrich R: Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. Mol Biol Cell. 1999, 10: 2493-2506. 10.1091/mbc.10.8.2493PubMedCentralCrossRefPubMed

18.

Carter S, Auer KL, Reardon DB, Birrer M, Fisher PB, Valerie K, Schmidt-Ullrich R, Mikkelsen R, Dent P: Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene. 1998, 16: 2787-2796. 10.1038/sj.onc.1201802CrossRefPubMed

19.

Reardon DB, Contessa JN, Mikkelsen RB, Valerie K, Amir C, Dent P, Schmidt-Ullrich RK: Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene. 1999, 18: 4756-4766. 10.1038/sj.onc.1202849CrossRefPubMed

20.

Baselga J, Mendelsohn J, Kim YM, Pandiella A: Autocrine regulation of membrane transforming growth factor-alpha cleavage. J Biol Chem. 1996, 271: 3279-3284. 10.1074/jbc.271.6.3279CrossRefPubMed

21.

Levenson AS, Tonetti DA, Jordan VC: The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor. Br J Cancer. 1998, 77: 1812-1819. 10.1038/bjc.1998.301PubMedCentralCrossRefPubMed

22.

Pages G, Milanini J, Richard DE, Berra E, Gothie E, Vinals F, Pouyssegur J: Signaling angiogenesis via p42/p44 MAP kinase cascade. Ann N Y Acad Sci. 2000, 902: 187-200.CrossRefPubMed

23.

Li Y, Bi Z, Yan B, Wan Y: UVB radiation induces expression of HIF-1alpha and VEGF through the EGFR/PI3K/DEC1 pathway. Int J Mol Med. 2006, 18: 713-719.PubMed

24.

Di Girolamo N, Coroneo M, Wakefield D: Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation. Am J Pathol. 2005, 167: 489-503. 10.1016/S0002-9440(10)62992-6PubMedCentralCrossRefPubMed

25.

Jung SK, Lee KW, Kim HY, Oh MH, Byun S, Lim SH, Heo YS, Kang NJ, Bode AM, Dong Z, Lee HJ: Myricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting Raf. Biochem Pharmacol. 2010, 79: 1455-1461. 10.1016/j.bcp.2010.01.004PubMedCentralCrossRefPubMed

26.

Bucci B, D’Agnano I, Botti C, Mottolese M, Carico E, Zupi G, Vecchione A: EGF-R expression in ductal breast cancer: proliferation and prognostic implications. Anticancer Res. 1997, 17: 769-774.PubMed

27.

LeMaistre CF, Meneghetti C, Howes L, Osborne CK: Targeting the EGF receptor in breast cancer treatment. Breast Cancer Res Treat. 1994, 32: 97-103. 10.1007/BF00666210CrossRefPubMed

28.

Toi M, Hoshina S, Takayanagi T, Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Gan. 1994, 85: 1045-1049. 10.1111/j.1349-7006.1994.tb02904.xPubMed

29.

Wedge SR, Ogilvie DJ, Dukes M, Kendrew J, Chester R, Jackson JA, Boffey SJ, Valentine PJ, Curwen JO, Musgrove HL: ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. Cancer Res. 2002, 62: 4645-4655.PubMed

30.

Ciardiello F, Caputo R, Damiano V, Troiani T, Vitagliano D, Carlomagno F, Veneziani BM, Fontanini G, Bianco AR, Tortora G: Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. Clin Cancer Res. 2003, 9: 1546-1556.PubMed

31.

Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, Mandal M: ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells. Cancer Biol Ther. 2010, 9: 592-603. 10.4161/cbt.9.8.11103CrossRefPubMed

32.

Arao T, Fukumoto H, Takeda M, Tamura T, Saijo N, Nishio K: Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474. Cancer Res. 2004, 64: 9101-9104. 10.1158/0008-5472.CAN-04-2360CrossRefPubMed

33.

Rustogi A, Budrukkar A, Dinshaw K, Jalali R: Management of locally advanced breast cancer: evolution and current practice. J Cancer Res T. 2005, 1: 21-30. 10.4103/0973-1482.16086. 10.4103/0973-1482.16086CrossRef

34.

Foekens JA, Peters HA, Grebenchtchikov N, Look MP, Meijer-van Gelder ME, Geurts-Moespot A, van der Kwast TH, Sweep CG, Klijn JG: High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Cancer res. 2001, 61: 5407-5414.PubMed

35.

Neskovic-Konstantinovic Z, Nikolic-Vukosavljevic D, Brankovic-Magic M, Kanjer K, Gavrilovic D, Mitrovic L, Borojevic N, Vukotic D, Spuzic I: Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease. J Exp Clin Cancer Res. 1999, 18: 347-355.PubMed

36.

Dunkern TR, Fritz G, Kaina B: Ultraviolet light-induced DNA damage triggers apoptosis in nucleotide excision repair-deficient cells via Bcl-2 decline and caspase-3/-8 activation. Oncogene. 2001, 20: 6026-6038. 10.1038/sj.onc.1204754CrossRefPubMed

37.

Kulms D, Poppelmann B, Yarosh D, Luger TA, Krutmann J, Schwarz T: Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation. Proc Natl Acad Sci U S A. 1999, 96: 7974-7979. 10.1073/pnas.96.14.7974PubMedCentralCrossRefPubMed

38.

Murahashi H, Azuma H, Zamzami N, Furuya KJ, Ikebuchi K, Yamaguchi M, Yamada Y, Sato N, Fujihara M, Kroemer G, Ikeda H: Possible contribution of apoptosis-inducing factor (AIF) and reactive oxygen species (ROS) to UVB-induced caspase-independent cell death in the T cell line Jurkat. J Leukoc Biol. 2003, 73: 399-406. 10.1189/jlb.0702335CrossRefPubMed

39.

Maeda T, Chua PP, Chong MT, Sim AB, Nikaido O, Tron VA: Nucleotide excision repair genes are upregulated by low-dose artificial ultraviolet B: evidence of a photoprotective SOS response?. J Invest Dermatol. 2001, 117: 1490-1497. 10.1046/j.0022-202x.2001.01562.xCrossRefPubMed

40.

Owen JB, Coia LR, Hanks GE: Recent patterns of growth in radiation therapy facilities in the United States: a patterns of care study report. Int J Radiat Oncol Biol Phys. 1992, 24: 983-986. 10.1016/0360-3016(92)90483-XCrossRefPubMed

41.

McGinn CJ, Lawrence TS: Recent advances in the use of radiosensitizing nucleosides. Semin Radiat Oncol. 2001, 11: 270-280. 10.1053/srao.2001.26002CrossRefPubMed

42.

Wurschmidt F, Dahle J, Petersen C, Wenzel C, Kretschmer M, Bastian C: Reirradiation of recurrent breast cancer with and without concurrent chemotherapy. Radiat Oncol. 2008, 3: 28- 10.1186/1748-717X-3-28PubMedCentralCrossRefPubMed

43.

Kao J, Conzen SD, Jaskowiak NT, Song DH, Recant W, Singh R, Masters GA, Fleming GF, Heimann R: Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials. Int J Radiat Oncol Biol Phys. 2005, 61: 1045-1053. 10.1016/j.ijrobp.2004.07.714CrossRefPubMed

44.

Scappaticci FA: Mechanisms and future directions for angiogenesis-based cancer therapies. J Clin Oncol. 2002, 20: 3906-3927. 10.1200/JCO.2002.01.033CrossRefPubMed

45.

Gorski DH, Mauceri HJ, Salloum RM, Gately S, Hellman S, Beckett MA, Sukhatme VP, Soff GA, Kufe DW, Weichselbaum RR: Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res. 1998, 58: 5686-5689.PubMed

46.

Griffin RJ, Williams BW, Wild R, Cherrington JM, Park H, Song CW: Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response. Cancer Res. 2002, 62: 1702-1706.PubMed

47.

Wondrak GT, Jacobson MK, Jacobson EL: Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photoprotection. Photochem Photobiol Sci. 2006, 5: 215-237. 10.1039/b504573hCrossRefPubMed

48.

Weischer M, Blum A, Eberhard F, Rocken M, Berneburg M: No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol. 2004, 84: 370-374. 10.1080/00015550410026948CrossRefPubMed

49.

Hirakawa S, Fujii S, Kajiya K, Yano K, Detmar M: Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage. Blood. 2005, 105: 2392-2399. 10.1182/blood-2004-06-2435CrossRefPubMed

50.

Sasaki K, Tsuno NH, Sunami E, Kawai K, Shuno Y, Hongo K, Hiyoshi M, Kaneko M, Murono K, Tada N: Radiosensitization of human breast cancer cells to ultraviolet light by 5-fluorouracil. Oncology letters. 2011, 2: 471-476.PubMedCentralPubMed

51.

Williams KJ, Telfer BA, Brave S, Kendrew J, Whittaker L, Stratford IJ, Wedge SR: ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity. Clin Cancer Res. 2004, 10: 8587-8593. 10.1158/1078-0432.CCR-04-1147CrossRefPubMed

52.

Allan LA, Fried M: p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis. Oncogene. 1999, 18: 5403-5412. 10.1038/sj.onc.1202931CrossRefPubMed

53.

Wu Y, Xing D, Chen WR, Wang X: Bid is not required for Bax translocation during UV-induced apoptosis. Cellular signalling. 2007, 19: 2468-2478. 10.1016/j.cellsig.2007.07.024CrossRefPubMed

54.

Sarkar S, Mandal M: Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer. Breast Cancer Res. 2009, 3: 47-60.

55.

Geyer RK, Nagasawa H, Little JB, Maki CG: Role and regulation of p53 during an ultraviolet radiation-induced G1 cell cycle arrest. Cell growth differ. 2000, 11: 149-156.PubMed

56.

Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, Mandal M: ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells. J Cell Physiol. 2011, 226: 375-384. 10.1002/jcp.22343CrossRefPubMed

57.

Bortner DM, Rosenberg MP: Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol. 1997, 17: 453-459.PubMedCentralCrossRefPubMed

58.

Yu Q, Geng Y, Sicinski P: Specific protection against breast cancers by cyclin D1 ablation. Nature. 2001, 411: 1017-1021. 10.1038/35082500CrossRefPubMed

59.

Sgambato A, Camerini A, Pani G, Cangiano R, Faraglia B, Bianchino G, De Bari B, Galeotti T, Cittadini A: Increased expression of cyclin E is associated with an increased resistance to doxorubicin in rat fibroblasts. Br J Cancer. 2003, 88: 1956-1962. 10.1038/sj.bjc.6600970PubMedCentralCrossRefPubMed

60.

Panno ML, Giordano F, Mastroianni F, Palma MG, Bartella V, Carpino A, Aquila S, Ando S: Breast cancer cell survival signal is affected by bergapten combined with an ultraviolet irradiation. FEBS letters. 2010, 584: 2321-2326. 10.1016/j.febslet.2010.04.001CrossRefPubMed

61.

Knezevic D, Zhang W, Rochette PJ, Brash DE: Bcl-2 is the target of a UV-inducible apoptosis switch and a node for UV signaling. Proc Natl Acad Sci U S A. 2007, 104: 11286-11291. 10.1073/pnas.0701318104PubMedCentralCrossRefPubMed

62.

Knezevic D, Brash DE: Role of E2F1 in apoptosis: a case study in feedback loops. Cell Cycle. 2004, 3: 729-732.CrossRefPubMed

63.

VonderMark K, Schober S, Goodman SL: Integrins in cell migration. Methods Mol Biol. 1999, 129: 219-230.

64.

Cho SY, Klemke RL: Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix. J Cell Biol. 2000, 149: 223-236. 10.1083/jcb.149.1.223PubMedCentralCrossRefPubMed

65.

Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL: HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol. 2001, 21: 3995-4004. 10.1128/MCB.21.12.3995-4004.2001PubMedCentralCrossRefPubMed

66.

Trompezinski S, Pernet I, Schmitt D, Viac J: UV radiation and prostaglandin E2 up-regulate vascular endothelial growth factor (VEGF) in cultured human fibroblasts. Inflamm Res. 2001, 50: 422-427. 10.1007/PL00000265CrossRefPubMed

67.

Duband JL, Dufour S, Yamada SS, Yamada KM, Thiery JP: Neural crest cell locomotion induced by antibodies to beta 1 integrins. A tool for studying the roles of substratum molecular avidity and density in migration. J Cell Sci. 1991, 98 (Pt 4): 517-532.PubMed

68.

DiMilla PA, Stone JA, Quinn JA, Albelda SM, Lauffenburger DA: Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J cell biolgy. 1993, 122: 729-737. 10.1083/jcb.122.3.729. 10.1083/jcb.122.3.729CrossRef

69.

Van de Water B, Kruidering M, Nagelkerke JF: F-actin disorganization in apoptotic cell death of cultured rat renal proximal tubular cells. Am J Physiol. 1996, 270: F593-603.PubMed

70.

Dash R, Mandal M, Ghosh SK, Kundu SC: Silk sericin protein of tropical tasar silkworm inhibits UVB-induced apoptosis in human skin keratinocytes. Mol Cell Biochem. 2008, 311: 111-119. 10.1007/s11010-008-9702-zCrossRefPubMed

71.

Yasugi E, Kumagai T, Nishikawa Y, Okuma E, Saeki K, Oshima M, Susin SA, Kroemer G, Yuo A: Involvement of apoptosis-inducing factor during dolichyl monophosphate-induced apoptosis in U937 cells. FEBS letters. 2000, 480: 197-200. 10.1016/S0014-5793(00)01925-6CrossRefPubMed

72.

Mandal M, Adam L, Mendelsohn J, Kumar R: Nuclear targeting of Bax during apoptosis in human colorectal cancer cells. Oncogene. 1998, 17: 999-1007. 10.1038/sj.onc.1202020CrossRefPubMed

73.

Huh JE, Kang KS, Chae C, Kim HM, Ahn KS, Kim SH: Roles of p38 and JNK mitogen-activated protein kinase pathways during cantharidin-induced apoptosis in U937 cells. Biochem Pharmacol. 2004, 67: 1811-1818. 10.1016/j.bcp.2003.12.025CrossRefPubMed

74.

Liang CC, Park AY, Guan JL: In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007, 2: 329-333.CrossRefPubMed

75.

Murata J, Ayukawa K, Ogasawara M, Fujii H, Saiki I: Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells. Invasion Metastasis. 1997, 17: 82-93.PubMed

Title: Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells
Authors: Siddik Sarkar
Shashi Rajput
Amit Kumar Tripathi
Mahitosh Mandal
Publication date: 01-12-2013
Publisher: BioMed Central
Published in: Molecular Cancer / Issue 1/2013
Electronic ISSN: 1476-4598
DOI: https://doi.org/10.1186/1476-4598-12-122

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2013

PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling

The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma

The identification of novel targets of miR-16 and characterization of their biological functions in cancer cells

Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer

Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis

Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines

Keynote webinar | Spotlight on antibody–drug conjugates in cancer